Table 1. Epidemiological and clinical characteristics of study subjects.
ccRCC patients | Healthy controls | |
---|---|---|
N = 69 | N = 36 | |
Male (N, proportion) | 50 (0.72) | 24 (0.67) |
Age (years) | 66 (33-87) | 65 (40-79) |
pT stage* | ||
pT1 | 54 | NA |
pT2 | 4 | NA |
pT3 | 11 | NA |
pT4 | 0 | NA |
pN stage* | ||
pN0 | 69 | NA |
pN1 | 0 | NA |
pM stage* | ||
pM0 | 69 | NA |
pM1 | 0 | NA |
Fuhrman grade† | ||
G1 | 11 | NA |
G2 | 40 | NA |
G3 | 13 | NA |
G4 | 5 | NA |
*pT,N,M stages accordingly to American Joint Committee on Cancer Staging Manual. †The grading scheme used in RCC. RCC - renal cell carcinoma, ccRCC - clear-cell renal cell carcinoma, NA - not applicable. |